Altering the rehabilitation environment to improve stroke survivor activity: A Phase II trial.
Janssen H, Ada L, Middleton S, Pollack M, Nilsson M, Churilov L, Blennerhassett J, Faux S, New P, McCluskey A, Spratt NJ, Bernhardt J; AREISSA Trial group.
Janssen H, et al.
Int J Stroke. 2022 Mar;17(3):299-307. doi: 10.1177/17474930211006999. Epub 2021 Apr 13.
Int J Stroke. 2022.
PMID: 33739202
Clinical Trial.